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Background. Central poststroke pain (CPSP) caused by sensory dysfunction of central origin is a disabling condition that
significantly affects the quality of life of stroke patients. Aim. The aim of this study is to determine the clinical profiles and
pattern of CPSP among stroke patients in Kano, Nigeria. Methods. The study was a cross-sectional design involving stroke
survivors who were≥18 years old and with no significant cognitive impairment approved by the Research Ethics Committee of
Aminu Kano Teaching Hospital. Participants were assessed using diagnostic criteria form, the douleur neuropathique 4
questions (DN4 questionnaire), and Leeds assessment of neuropathic symptoms and signs (LANNS). Results. A total of 120
stroke patients participated in the study, in which 6 (5%) were diagnosed with CPSP occurring within the first 3 months in 50%
of the participants. The pain characteristics were mainly moderate (83.3%), burning (62.5%), and continuously experienced
(66.7%). The frequently affected parts were extremities or occurring as hemisyndrome. Conclusion. Prevalence of CPSP
following stroke is low. The clinical features are variable and can occur at a varied time and different intensities and locations.
However, it majorly occurs within the first few months post stroke.
1. Introduction
Stroke is now an important public health concern. It is clas-
sically characterized as a neurological deficit attributed to
an acute focal injury of the central nervous system (CNS)
by a vascular cause, including cerebral infarction, intracere-
bral hemorrhage (ICH), and subarachnoid hemorrhage
(SAH) [1]. When stroke occurs, there may be impairment
in the brain’s control of motor, sensory, and cognitive func-
tions in combination with one another or all. One of the
impairments in sensory functions following stroke is central
poststroke pain (CPSP).
Central poststroke pain (CPSP) is a constant or intermit-
tent pain reported by patients after stroke that is usually asso-
ciated with sensory abnormalities such as decreased
perception of harmful and sharp stimuli [2]. The symptoms
may affect the patients’ ability to carry out their activities of
daily living, cause emotional disturbances, and decrease the
patients’ quality of life [3–5].
Although, there remain some mysteries as to the patho-
physiology of CPSP, it is believed to be caused by stroke in
the region of the thalamus [6] and extrathalamic areas [7].
The thalamus is a relay station for sensory information from
all over the body. Subsequently, it was coined initially as tha-
lamic pain syndrome (TPS) by Dejerine and Roussy in 1906
[8]; and so far, there have been different treatments for it.
The treatments of CPSP involve pharmacologic or nonphar-
macologic treatment. The pharmacologic treatment includes
the use of antidepressants [3] and opioids such as morphine
[9]. The nonpharmacological treatment includes the use of
repetitive transmagnetic stimulation [10], deep brain stimu-
lation [11], and vestibular caloric stimulation [12]. Despite
these available treatments, CPSP is a difficult condition as it
is usually underreported probably due to payment of atten-
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tion majorly on motor impairment and spasticity by the cli-
nicians [13]. Furthermore, as stroke is now increasingly
becoming a leading cause of disability in the developing
countries such as Nigeria [14], there may be likelihood of
having increased prevalence of CPSP among the survivors.
Therefore, understanding the profiles of any of its symptoms
is important for healthcare planning, management, and reha-
bilitation. The aim of this study is to look at the profiles of
CPSP and gender difference in the profiles among stroke sur-
vivors in Kano, Nigeria. Thus, the study will answer the
research question what is the profile of PSCP among stroke
survivors in Kano state, Nigeria. The answer to this question
will help clinicians and researcher alike to better understand
the profile and extent PSCP in the given population and work
for better therapeutic intervention for it.
2. Material and Methods
2.1. Participants and Recruitments. The study was a cross-
sectional (observational) study approved by the Research
Ethics Committee of Kano State Hospitals Management
Board which caters for all the hospitals under the jurisdiction
of the state government. The population of the study was
patients with stroke attending outpatient physiotherapy
departments at Murtala Muhammad Specialists Hospital
(MMSH) and Muhammad Abdullahi Wase Specialist Hospi-
tal (MAWSH) in Kano. Participants were sampled using con-
venience sampling technique using the following inclusion
criteria: adult stroke patients who are 18 years of age or above
and patients with no significant cognitive impairment (Mini-
Mental State Examination (MMSE) >17).
2.2. Procedure. The nature and procedure of the study were
explained to the participants, and those who signed the
informed consent form were interviewed. Information about
demographic characteristics of the study participants, stroke
condition, and pain were obtained and documented in diag-
nostic criteria form. The diagnostic criteria form used by Klit
and his colleagues were used to assess for participants who
are suspected to have CPSP [15]. The criteria are as follows:
having other pain other than the ones listed in the form; pres-
ence of abnormal sensation, whether the side of the abnormal
sensation corresponds with the area of other pain; anatomi-
cally probable distribution of the indicated areas of altered
sensation or pain that is either unilateral or crossed head/
body distribution; and absence of any other obvious cause
of the pain such as nociceptive or psychogenic.
Other instruments used in the study include pain assess-
ment record form for collecting the details on the pain char-
acteristics such as onset, description, abnormal sensation and
its description, brush for testing dynamic allodynia, tooth-
pick used for testing pinprick hyperalgesia, test tube for heat
(40°) and cold (15°) sensation, and alcohol for sterilization.
Pinprick and thermal (heat and cold) sensations were tested
at the patients’ pain location at the interval of 5 minutes each.
Additionally, the douleur neuropathique 4 questions (DN4
questionnaire) and Leeds assessment of neuropathic symp-
toms and signs (LANNS) were also used.
The DN4 questionnaire is a 4-item questionnaire devel-
oped by Bouhassira and colleagues [16]. It is a reliable scale
that differentiates between neuropathic pain and nonneuro-
pathic pain [17]. Similarly, the LANNS is a valid instrument
that distinguishes nociceptive pain from neuropathic pain
[18, 19]. It consists of 2 sections: pain questionnaire which
has 5 items and sensory testing which has 2 items [18].
2.3. Data Analysis Procedure. The demographic characteris-
tics of the study participants and their CPSP clinical profiles
were analyzed using descriptive statistics of mean, frequency,
and percentage. The gender difference in the clinical profiles
was analyzed using Mann–Whitney U test. All analyses were
carried out using SPSS version 16.
3. Result
A total of 124 patients were contacted for the study; out of
this, 4 refused to participate. One hundred and twenty
patients were interviewed in which 20 were suspected to be
having CPSP. After sensory and clinical examinations, 6
patients were diagnosed with CPSP corresponding to an inci-
dence of CPSP of 5% in the study population.
Out of the 120 stroke patients assessed, 57 (47.5%) were
male and 63 (52.5%) were female with mean age of 55.8
± 10.9. For the participants diagnosed with CPSP, 4 (66.7%)
were male and 2 (33.3%) were female with mean age of
59.3± 9.4 (47–73). All of the participants with CPSP had
ischemic stroke, and one had recurrence of the stroke within
1 year. See Table 1 for the demographic characteristics of the
participants diagnosed with CPSP.
The average period of the onset of stroke to the time
of the study was 11± 5.7 months, and average period of
pain onset from stroke onset was 4.2± 4.3 months. One
(16.7%) of the participants started experiencing chronic
pain immediately after stroke; in 3 of the participants
(50%), the pain onset was within 3 months after onset of
stroke; and in 2 of the participants (33.3%), the pain was
after 6 months. Majority of the participants were
experiencing moderate pain (83.3%) and the rest, severe.
Four (66.7%) of the participants reported the pain to be
Table 1: Summary of the demographic characteristics and pain
scores of participants diagnosed with CPSP.
Variable N %
Patients diagnosed with CPSP 6 out of 120 5
Male with CPSP 4 out of 57 7
Female with CPSP 2 out of 63 3.2
Mean age 59.3± 9.4
Mean period of onset of stroke 11± 5.7 months
Mean period of pain onset 4.2± 4.3 months
Mean VAS score 6.2± 1.2
Average DN4 scores 5.5± 1.0
Average LANNS scores 16.2± 2.1
N: frequency; %: percentage; DN4: douleur neuropathique 4 questions;
LANSS: Leeds assessment of neuropathic symptoms and signs.
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continuous and had experienced change in pain from its
onset. Burning sensation (62.5%) is the most reported pain
descriptor followed by electric shock. At least 2 (33.3%) of
the participants had more than one pain descriptor, and 1
(16.7%) had 3 pain descriptors. All the participants had 1
or 2 other associated poststoke pains, 50% had painful
shoulder, and 20% had spasticity related pain. See
Table 2 for more detail.
The main aggravating factors reported were psycholog-
ical stress, contact to cold/heat, and movement of the
limb. The average DN4 questionnaire and LANNS scores
were 5.5± 1.0 and 16.2± 2.1, respectively, indicating that
neuropathic mechanisms are contributing or responsible
to the patient symptoms. Pain location and distribution
were multifocal (90.9%) in almost all the participants.
The main sensory abnormalities were tactile allodynia
(35.7%) and pinprick hyperalgesia (35.7%). About 33% of
the participants had 3 sensory abnormalities, and all had
more than one sensory abnormality as shown in Table 3.
About 50% of the participants were reported after sensa-
tion during the examination. Pins and needles were the
common abnormal sensation descriptor reported by 4
(44.4%) participants and tingling in 3 (33.3%) participants.
At least 2 of the participants had 3 sensation descriptors.
See Table 4 for more details.
For the difference in the clinical characteristics between
male and female participants diagnosed with CPSPS,
Mann–Whitney U test revealed that there was no significant
difference (p > 0 05). See Table 3 for more details of
the analysis.
4. Discussion
The aim of this study was to find out the profiles of CPSP in
Kano, Nigeria. The result of the study showed a CPSP preva-
lence of 5% which is within the range of 1–12% reported in
the literature by Klit and colleagues and Kong and colleagues
[15, 20–22]. Whereas, the study by Klit and colleagues was a
population based with a very large sample, and the present
study was hospital based. Consequently, it may be difficult
to categorically state that the prevalence rate well represents
that of Kano population especially that it is in a developing
country where there are still many challenges with stroke
rehabilitation as many stroke survivors may not be reported
or get access to quality care [23–25]. However, the low prev-
alence of CPSP reported in the present and previous studies
should not take precedence over the burden it may impose
on the patients in terms of interfering daily activities and
has a significant impact on their health-related quality of life




Inferior upper limb 2 18.2
Inferior lower limbs (leg & foot) 2 18.2
Superior upper limb (arm) 1 9.1




Immediately after stroke 1 16.7
Within 3 months after stroke 3 50
Six months after stroke 2 33.3
Pain intensity (VAS scores)
Moderate (4–7) 5 83.3








Shoulder pain 5 50
Headache 1 10
Spasticity-related pain 2 20
Joint pain 2 20
N: frequency; %: percentage.










Prevalence m 4 3.50 14.00 4.00 1.000
Pain onset m 4 4.38 17.50 0.500 0.100
f 2 1.75 3.50
Pain m 4 3.25 13.00 3.000 0.576
Frequency f 2 4.00 8.00
Pain m 4 2.50 10.00 0.000 0.057
Intensity f 2 3.50 11.00
Pain m 4 3.00 12.00 2.000 0.157
Descriptors f 2 4.50 9.50
Sensory m 4 3.50 14.00 4.000 1.000
Abnormalities f 2 3.50 7.000
Sensation m 4 3.50 14.00 2.000 1.000
Descriptors f 2 3.50 7.00
DN4 scores m 4 3.12 12.50 2.500 0.475
f 2 4.25 8.50
LANSS m 4 4.12 16.50 1.500 0.240
Scores f 2 2.25 4.50
Other PSPs m 4 4.00 16.00 2.000 0.273
f 2 2.50 5.00
Pain change m 4 4.00 16.00 2.000 0.264
f 2 2.50 5.00
N: frequency; %: percentage; DN4: douleur neuropathique 4 questions;
LANSS: Leeds assessment of neuropathic symptoms and signs; PSPs:
poststroke pains.
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[20]. Therefore, very effective therapeutic interventions are
needed to help these patients.
The result also showed that the duration of CPSP onset
varies greatly. In the present study, about 50% of the partici-
pants had pain onset within the first three months and 16.7%
immediately after stroke. In consistent with our findings, pre-
viously, it was reported that CPSP occurs between 3 and 6
months post stroke [26]. However, it was said to be common-
est within the first few months post stroke [27]. Conse-
quently, it may be very advisable if clinicians are watchful
for the signs and symptoms of CPSP at any time post stroke.
This could help to forestall its attending effects on the well-
being of the patients.
Occurrence of CPSP may depend on gender. In this
study, CPSP is more prevalent in men than in women. How-
ever, it has been argued that gender is not a reliable predictor
of CPSP as it may be more prevalent in either men or women
[7]. Additionally, the pain intensity in the study was moder-
ate in about 80% of participants which is similar to the find-
ings of de Oliveira and colleagues [28]. Similarly, the location
and distribution were multifocal in most of the participants.
However, pain intensity, location, and distribution can
change. For instance, pain intensity can change from moder-
ate to severe especially that the onset can also vary [29, 30].
Thus, it is important for the clinicians to attend to the pain
at the onset to help prevent it from changing to severe form.
This is because, in this study, about 80% of the participants
reported change in the pain since its onset in either intensity
or distribution or both. Similar pain characteristics were also
reported by Klit and colleagues [15].
Central poststroke pain (CPSP) can occur alongside
other pain symptoms, though it is difficult to distinguish
between CPSP with other pain syndromes [31]. In this study,
each of participants had 1 or 2 other poststroke pains occur-
ring concomitantly. Out of these, shoulder pain accounted
for about 50% of the pains. Previous studies had similarly
showed the prevalence of shoulder pain in CPSP patients to
be 30–40% [30, 32]. Thus, pain management should be an
integral part of stroke rehabilitation. Additionally, we found
allodynia to be the most abnormal sensation accounting for
62.5% which is consistent with the findings of a previous
study [15]. However, the type of allodynia CPSP patients
may have depend on the lesion location in the thalamus
[33]; and those with normal tactile detection thresholds
may experience tactile allodynia significantly more often
than those with tactile hypoesthesia [34]. Furthermore, all
of our study participants had high DN4 and LANNS scores.
Similarly, it was previously reported that most of the patients
with CPSP had high DN4 questionnaire scores [15]. The
DN4 is very sensitive at selecting a subgroup of CPSP
patients with more severe pain and sensory abnormalities
[35]. This suggests that the participants’ symptoms are
results of neuropathic mechanism.
Poststroke central pain can have psychological impact on
the patients, reduces sleep quality, and interferes with activi-
ties of daily living. Previously, pain in stroke patients was
reported to result in sleep disturbance and general well-
being [36]; and pain, especially when it is chronic, can be
associated with depression [37]. These can eventually affect
health-related quality of life [20]. Additionally, the risk fac-
tors for CPSP include ischemic stroke (similarly, all the par-
ticipants in this study had ischemic stroke, though the
diagnosis was done only using clinical presentations as radio-
logical reports of the participants were not available),
impaired limb motor function, and presence of sensory
abnormalities [15, 37]. Thus, prevention of risk factors of
ischemic stroke, pain management and rehabilitation of sen-
sory, and motor function may help prevent the incidence of
CPSP or reduce its psychosocial and physical effects of CPSP
on the patients. However, the present study is limited by its
sample size.
5. Conclusion
Prevalence of CPSP following stroke is low. The clinical fea-
tures are variable and can occur at varied times and different
intensities and locations. However, it majorly occurs within
the first few months post stroke. Therefore, clinicians are
advised to be on the watch out for its signs and symptoms
in order to help forestall any possible burden it will impose
on the patients.
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